The Department of Health and Human Services is the Federal government's principal agency for protecting the health of all Americans and providing essential human services, especially to those who are least able to help themselves.
Uses and Use Restrictions
Project funds may be used for costs associated with planning, organizing, conducting, and supporting immunization programs directed toward vaccine-preventable diseases, and for the implementation of other program elements as described in Section 050 above and through CDC allowable and unallowable expenses.
Eligibility is limited to existing grantees under the Immunization Program (CFDA 93.268) which includes all 50 U.S.
states, the District of Columbia, local health departments (Chicago, Houston, New York City, Philadelphia, San Antonio) and U.S.
territories (Commonwealth of Puerto Rico, Virgin Islands, Commonwealth of the Northern Mariana Islands, American Samoa, Guam, Federated States of Micronesia, Republic of the Marshall Islands, Republic of Palau).
Private individuals, private nonprofit agencies, and Indian tribes are not eligible.
Any U.S. state, political subdivision and U.S. territories (as described above), and other public entities will benefit.
Applicants should document the need for assistance, state the objectives of the project, outline the method of operation, describe the evaluation procedures, and provide a budget with justification of funds. Costs will be determined in accordance with 2 CFR 225 (OMB Circular No. A-87) for state and local governments. OMB Circular No. A-87 applies to this program. 2 CFR 200, Subpart E - Cost Principles applies to this program.
Aplication and Award Process
Preapplication coordination is not applicable.
Environmental impact information is not required for this program.
This program is excluded from coverage under E.O.
This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. Pre-application coordination is not required. Environmental impact information is not required for this program. This program is eligible for coverage under E.O. 12372 ?Intergovernmental Review of Federal Programs.? An applicant should consult the office or official designated as the single point of contact in his or her state for more information on the process the state requires to be followed in applying for assistance, if the state has selected the program for review. This program is excluded from coverage under OMB Circular No. A-110. Allowable costs will be determined in accordance with OMB Circular No. A-87 for non-profit, non-governmental organizations. Applicants must download supplemental application forms from www.Grants.gov. Supplemental applications must be submitted electronically at www.Grants.gov. If an applicant does not have access to the Internet, or if they have difficulty accessing the forms online, contact the CDC Procurement and Grants Office, Technical Information Management Section (PGO-TIMS) staff. For this, or further assistance, contact PGO-TIMS: Telephone: 770-488-2700, email: PGOTIM@cdc.gov. HHS/CDC Telecommunications for the hearing impaired: TTY 770-488-2783.
All applications that are complete and responsive to competitive supplemental grant and cooperative agreement announcements will undergo an objective review process, receive a written critique and be scored according to published review criteria. Successful applicants will receive a Notice of Award (NoA) from the CDC Procurement and Grants Office. The NoA shall be the only binding, authorizing document between the recipient and CDC. The NoA will be signed by an authorized CDC Grants Management Officer.
Contact the headquarters or regional office, as appropriate, for application deadlines.
This program is authorized under Section 317 of the Public Health Service Act (42 U.S.C. Sections 247b), as amended; and the Patient Protection and Affordable Care Act (PL 111-148), Title IV, Sections 4002, (Prevention and Public Health Fund) for expanded and sustained national investment in prevention and public health programs. This program is funded in part by 2012 Prevention and Public Health Funds (PPHF-2012).
Range of Approval/Disapproval Time
Renewals will be based upon the conditions in the funding announcement and are subject to the availability of funds under the Patient Protection and Affordable Care Act.
Formula and Matching Requirements
This program has no statutory formula. This program has no matching requirements. This program does not have MOE requirements.
Length and Time Phasing of Assistance
Financial assistance is available for a 12-month budget period and 24-month project period. Method of awarding/releasing assistance: lump sum.
Post Assistance Requirements
The reporting schedule will be based on the requirements listed in the funding opportunity announcement.
No cash reports are required.
Funded applicants must provide a Monthly Progress Report within 30 days after the award and monthly thereafter.
An Annual Progress Report is due 90 days after the end of the budget period.
Federal Financial Reports (SF-425) and Final Progress Report are due 90 days after the end of the budget period.
Federal Financial Reports (SF-425) are due 90 days after the end of the budget period.
No performance monitoring is required.
In accordance with the provisions of 2 CFR 200, Subpart F - Audit Requirements, non-Federal entities that expend financial assistance of $750,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Non-Federal entities that expend less than $750,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in 2 CFR 200.503. Records must be available for review or audit by appropriate officials of the Federal agency, pass-through entity, and General Accounting Office (GAO). The grantee is to also ensure that the sub-recipients receiving CDC funds also meet these requirements (if total Federal grant or grants funds received exceed $500,000). The grantee should include this requirement in all sub-recipient contracts.
Financial records, supporting documents, statistical records, and all other records pertinent to the program shall be retained for a minimum of 3 years, or until completion and resolution of any audit in process or pending resolution. In all cases records must be retained until resolution of any audit questions. Property records must be retained in accordance with 45 CFR 92.42.
(Cooperative Agreements) FY 16 $0; FY 17 est $0; and FY 18 est $0 - Future funding is unknown and subject to availability of funds.
Range and Average of Financial Assistance
Award ranges and averages vary based on program areas and supplemental projects funded through these cooperative agreements.
Regulations, Guidelines, and Literature
Regulations governing this program are published under 42 CFR 55b. Guidelines are available for 45 CFR 92 and HHS Grants Policy statement at http://www.ahrq.gov/fund/hhspolicy.htm.
Regional or Local Office
Ivory Reid 1600 Clifton Road MSA19, Atlanta, Georgia 30333 Email: email@example.com Phone: 4046397824
Criteria for Selecting Proposals
Applications will be reviewed for completeness by the Procurement and Grants Office (PGO) staff and for responsiveness jointly by the National Center for Immunization and Respiratory Diseases and PGO. Incomplete applications and applications that are non-responsive to the eligibility criteria will not advance through the review process. Applicants will be notified if the application did not meet submission requirements. CDC will conduct a review to evaluate complete and responsive applications according to the criteria listed in Section V. Application Review Information within the individual funding announcement. Applicants will be notified if their application did not meet program requirements.